Prestige Consumer Healthcare (PBH) Asset Writedowns and Impairment (2018 - 2019)
Prestige Consumer Healthcare (PBH) recorded quarterly Asset Writedowns and Impairment of $229.5 million in Q1 2019, up 129.64% quarter-over-quarter from $99.9 million in Q1 2018, and up 129.64% on a YoY basis from $99.9 million in Q1 2018.
Prestige Consumer Healthcare (PBH) Asset Writedowns and Impairment (2018 - 2019) Analysis & Trends
Prestige Consumer Healthcare's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $229.5 million for Q1 2019.
- In Q1 2019, Asset Writedowns and Impairment rose 129.64% year-over-year to $229.5 million; the TTM figure through Mar 2019 stood at $229.5 million (up 129.64% YoY), while the FY2025 annual figure was $12.5 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $229.5 million for Q1 2019 at Prestige Consumer Healthcare, up from $99.9 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $229.5 million in Q1 2019 to a low of $99.9 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 229.46 Mn |
| Mar 31, 2019 | 229.46 Mn |
| Mar 31, 2018 | 99.92 Mn |
| Mar 31, 2018 | 99.92 Mn |